Drivers: Increasing incidence of cancer and HIV/AIDS

Diagnostic/ Prognostic information on clinical research on cancer and HIV/ AIDS can be derived using flow cytometry. Besides this, flow cytometry has applications such as the enumeration of helper T-cells (CD4 cells) in HIV infections, determining DNA content, and profiling tumor cells in breast cancer, lymphoma, leukemia, and other malignancies.

The fast-growing burden of cancer has led to a rise in the demand for oncology testing services (including cytometric analysis procedures). Moreover, factors such as growing lifestyle changes, unhygienic living conditions, and unsafe sexual behaviors have increased the risk of HIV infections. Therefore, the growing incidence of AIDS is expected to increase the use of diagnostic testing worldwide, in turn, driving the demand for flow cytometry products amp; services during the forecast period.

Challenges: Shortage of well-trained and skilled professionals

The operation of flow-cytometry instrumentation demands expertise and in-depth technical know-how about different control parameters, the range of available fluorescent-labeled compounds, protocols to design flow cytometry experiments, commonly-used reagents, and specific data analysis solutions. Flow cytometry techniques rely on operatorrsquo;s analytical process flow, including pipetting volume, sample integrity, and incubation time. A wide array of data outputs that require reviewing expertise is generated by technologically advanced and highly complex flow cytometers.

However, the absence of such expertise among researchers and clinicians limits the adoption of these advanced instruments. Besides, as per the opinion of most end users, they face difficulties finding expert trainers in the flow cytometry field in emerging Latin American countries. Thus, a shortage of expert professionals is expected to restrain the market to a certain extent.

Request to Get Customized Information@
https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=179088054

The Cell-based flow cytometry subsegment accounted for the largest share of the technology segment in the Latin American Flow Cytometry market in 2021.

On the basis of technology, the flow cytometry market in Latin America is segmented into cell-based flow cytometry and bead-based flow cytometry. The cell-based flow cytometry segment accounted for the largest share of this market. Cell-based flow cytometry tests compound activity against molecular targets within the context of living cells, and thus these tests are increasingly being used in drug discovery processes.

The research applications subsegment accounted for the largest share of the application segment in the Latin American Flow Cytometry market in 2021.

On the basis of application, the flow cytometry market is segmented into research, clinical, and industrial applications. The research applications subsegment accounted for the largest share of this market. Factors such as growing adoption of flow cytometry in research areas such as stem cell research, cancer research, and drug discovery contribute to the large share of this application.

The academic and research institutes subsegment accounted for the largest share of the application segment in the Latin American Flow Cytometry market in 2021.

On the basis of end user, the Latin American flow cytometry market is segmented into academic and research institutes, hospitals and clinical testing laboratories, and pharmaceutical and biotechnology companies. The academic and research institutes segment accounted for the largest market share. The growing focus of academic institutions on developing assays for innovative applications is driving the demand for flow cytometry products in this end-user segment.

Brazil is the largest country-level market and Mexico was the fastest-growing country of the Latin American Flow Cytometry market in 2021.

On the basis of country, the flow cytometry market in Latin America is segmented into Brazil, Mexico, Argentina, Colombia, Chile, and the Rest of Latin America. Brazil accounted for the largest share of the Latin American flow cytometry market. Factors such as the growing emphasis on cancer research, the development of effective treatments, and support for the improvement of scientific research in the country contribute to the large share of Brazil in the Latin American flow cytometry market.

Global Key Players:

Key players in the Latin American Flow Cytometry market are Becton, Dickinson and Company (US), Danaher Corporation (US), Thermo Fisher Scientific, Inc. (US), Agilent Technologies, Inc. (US), Bio-Rad Laboratories, Inc. (US), Miltenyi Biotec GmbH (Germany), Cytek Biosciences, Inc. (US), and Luminex Corporation (US).

Inquire More About This Study for More Detailed Information@
https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=179088054

Global Revenue Growth Dynamics:

This market is projected to reach USD 379 million by 2027, at a CAGR of 7.1% between 2022 and 2027.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]